Glenn R Larsen Net Worth & Insider Trades

Glenn R Larsen - Director, Anika Therapeutics, Inc

As of June 10, 2022

What is Glenn R Larsen's Net Worth?

The current estimated net worth of Anika Therapeutics, Inc's Director, Glenn R Larsen, is estimated to be about $506.95K . Glenn R Larsen owns about 7,590 units of Anika Therapeutics, Inc common stock. In the last 3 years at Anika Therapeutics, Inc, Glenn R Larsen has sold an estimated value of $249.15K worth.

What is Glenn R Larsen's Past Insider Trading?

Glenn R Larsen's largest sale order was 4,355 units , worth over $249.15K on August 30, 2019. In total, Glenn R Larsen has made about 5 transactions over 3 years of their time at Anika Therapeutics, Inc. Glenn R Larsen usually trades in February and June, with the busiest year in 2019.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Glenn R Larsen's' Mailing Address?

  • Mailing address is 32 Wiggins Avenue Bedford MA 01730 MA

Anika Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Other Earnings Plans or Compensations
Option Awards
Other Compensation
Total
Cheryl R. Blanchard, Ph.D. 2020 $548,077 $458,510 $5,335,439 $3,659,450 $27,958 $10,029,434
Michael L. Levitz 2020 $173,077 $73,601 $799,971 $799,993 $11,318 $1,857,960
David Colleran 2020 $344,077 $143,931 $645,900 $553,445 $18,263 $1,705,616
Thomas Finnerty 2020 $353,505 $143,169 $626,367 - $20,746 $1,143,787
James Loerop 2020 $381,563 $171,703 $464,449 - $22,156 $1,039,871
Joseph G. Darling 2020 $80,752 - - - $208,001 $288,753
Sylvia Cheung 2020 $294,252 - $924,637 - $89,644 $1,308,534
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/898437/000117184321002976/def14a_042921.htm

What are Anika Therapeutics, Inc's Past Insider Trades?

Anika Therapeutics, Inc's most recent insider trade came on May 12, 2022 by David Colleran who bought 1,500 units worth $32.05K . In the last 18 years, insiders at Anika Therapeutics, Inc have sold an estimated value of $66.56M and bought an estimated value of $5.82M worth of shares. Insider trading is most common in February, with the busiest year in 2006 and 2017. The most active traders at the company are Charles H Sherwood, CEO and Director,  Steve Wheeler, Director,  and Joseph L Bower, Director .

Anika Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1